All lobbying filings

FARRAGUT PARTNERS LLP

Lobbying for REPLIMUNE · Biotech

Filing 1st Quarter - Termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jul 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Representation ended

Jan 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 7

JEFF MACKINNON

Previously held: LD & LA Rep. Joe Barton (RTexas)
SARAH WALTER

Previously held: Former Legislative Director/Chief Counsel, Sen. John Breaux
EDWARD WHITFIELD

Previously held: U.S. Representative (21 yrs.)
JEFFERY C. MORTIER

Previously held: Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
KRISTEN BAUTZ

Previously held: Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
DYLAN MOORE

Previously held: Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)
CONSTANTINE HINGSON

Previously held: Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

Food & Drug Administration (FDA)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

issues related to advanced melanoma cancer treatments

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.